Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-12 5:35 pm Unchanged | 13D | PASSAGE BIO INC PASG | ORBIMED ADVISORS LLC | 8,034,000 13% | 0 (Unchanged) | View |
| 2024-04-04 4:39 pm Purchase | 13D | ENLIVEN THERAPEUTICS INC ELVN | ORBIMED ADVISORS LLC | 8,951,463 19.2% | 2,124 (+0.02%) | View |
| 2024-03-28 4:28 pm Purchase | 13D | Q32 BIO INC QTTB | ORBIMED ADVISORS LLC | 2,252,987 18.9% | 2,252,987 (New Position) | View |
| 2024-03-22 4:59 pm Unchanged | 13D | COMPASS THERAPEUTICS INC CMPX | ORBIMED ADVISORS LLC | 18,791,422 13.7% | 0 (Unchanged) | View |
| 2024-03-21 4:31 pm Unchanged | 13D | ADICET BIO INC ACET | ORBIMED ADVISORS LLC | 9,772,598 11.9% | 0 (Unchanged) | View |
| 2024-03-08 4:34 pm Sale | 13D | NEXTCURE INC NXTC | ORBIMED ADVISORS LLC | 1,268,013 4.5% | -1,443,000 (-53.23%) | View |
| 2024-02-21 4:11 pm Unchanged | 13D | KINNATE BIOPHARMA INC KNTE | ORBIMED ADVISORS LLC | 7,559,729 16.1% | 0 (Unchanged) | View |
| 2024-02-14 7:45 pm Sale | 13G | ALX ONCOLOGY HLDGS INC ALXO | ORBIMED ADVISORS LLC | 2,255,000 4.5% | -11,000 (-0.49%) | View |
| 2024-02-14 7:41 pm Purchase | 13G | INSPIREMD INC NSPR | ORBIMED ADVISORS LLC | 2,133,405 9.9% | 2,133,405 (New Position) | View |
| 2024-02-14 7:36 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | ORBIMED ADVISORS LLC | 11,494,437 6.7% | 1,165,788 (+11.29%) | View |
| 2024-02-14 7:31 pm Purchase | 13G | VERASTEM INC VSTM | ORBIMED ADVISORS LLC | 1,529,115 6.1% | 1,529,115 (New Position) | View |
| 2024-02-14 7:28 pm Sale | 13G | SI-BONE INC SIBN | ORBIMED ADVISORS LLC | 2,144,631 5.3% | -1,056,469 (-33.00%) | View |
| 2024-02-14 7:21 pm Purchase | 13G | SCHOLAR ROCK HLDG CORP SRRK | ORBIMED ADVISORS LLC | 2,960,000 4.1% | 2,960,000 (New Position) | View |
| 2024-02-14 7:11 pm Sale | 13G | PROTARA THERAPEUTICS INC TARA | ORBIMED ADVISORS LLC | 0 0% | -671,741 (Position Closed) | View |
| 2024-02-14 7:00 pm Sale | 13G | NEUROPACE INC NPCE | ORBIMED ADVISORS LLC | 4,003,967 15.2% | -8,314 (-0.21%) | View |
| 2024-02-14 6:55 pm Sale | 13G | MERSANA THERAPEUTICS INC MRSN | ORBIMED ADVISORS LLC | 0 0% | -7,082,837 (Position Closed) | View |
| 2024-02-14 6:51 pm Sale | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | ORBIMED ADVISORS LLC | 0 0% | -10,378,591 (Position Closed) | View |
| 2024-02-14 6:47 pm Sale | 13G | KEZAR LIFE SCIENCES INC KZR | ORBIMED ADVISORS LLC | 1,927,000 2.7% | -1,568,122 (-44.87%) | View |
| 2024-02-14 6:42 pm Purchase | 13G | ELEVATION ONCOLOGY INC ELEV | ORBIMED ADVISORS LLC | 3,000,000 6.8% | 3,000,000 (New Position) | View |
| 2024-02-14 6:36 pm Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | ORBIMED ADVISORS LLC | 1,667,360 2.5% | -1,529,516 (-47.84%) | View |